Coronary Stent

Sirolimus covers a CoCr drug-eluting stent known as GuReater®. The 75 μm CoCr strut of the device guarantees exceptional compliance following implantation by ensuring super flexibility and crossability.Product Features:input:
output:*The biocompatibility and radiopacity of the CoCr stent are exceptional.

*The stent’s exceptional flexibility during delivery is ensured by the 75μm ultrathin strut, which also facilitates effective endothelialization.

*The CoCr stent’s low recoil ratio of 3.4% guarantees improved stent apposition, thereby reducing the risk of thrombosis.

*The PLGA biodegradable polymer coating offers a scientific degradation period and precise drug-releasing control.

The stent’s exceptional compliance during delivery is ensured by the 75 μm ultrathin strut thickness and distinctive strut structure.

*The CoCr stent is highly biocompatible and radiopace, and it strikes an optimal balance between radial strength and flexibility.*MRI compatibleinput:
output:Quality Tracking Research on a Large Scaleinput:
output:*2,022 subjects, 22 hospitals

*The primary follow-up was the occurrence of adverse events in 1699 cases over a 12-month period.*50 cases experienced adverse events (2.94%), 2 cases died (0.12%), all of which were non-cardiac deaths, and 4 cases underwent non-target blood vessel revascularization (0.24%).input:
output:Verifies the safety and efficacy of the GuReater® Sirolimus-eluting Coronary Stent System in a diverse array of patients and the comprehensive performance of the lesion. GuReater is a product that has a significant clinical application.input:
output:Product Linesinput:
output:
*2.25-4.5 millimeters*Multi-stent lengths ranging from 8 to 36 millimeters